semaglutide banned by fda issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Ends Semaglutide Shortage Listing,

Theres no sugar coating (pun intended) the fact that many of the good things GLP-1s do for your health and weight loss are suspended when you stop taking a GLP-1

The inclusion in another largely unexplored dimension, as the potential role it may have on the gut-microbiota-brain axis is also interesting

[1] [2] If dyspnea occurs with signs of hypersensitivity or anaphylaxis, the medication should be discontinued immediately and emergency care sought

First approved for type 2 diabetes as Ozempic, the higher-dose Wegovy is intended for chronic weight management, delivering semaglutide at 15-20% of the body weight. It acts on GLP-1 receptors in the pancreas, promoting insulin secretion and reducing glucagon, which regulates blood sugar